Takeda Consumer Healthcare researches, develops, manufactures, sells, and markets over-the-counter pharmaceutical products and quasi-drugs.
The transaction marks Blackstone’s second private equity transaction in Japan’s healthcare sector following the acquisition of AYUMI Pharmaceutical in 2019.